Top 10 Health Information Services Stocks Outpacing The Market In 2025

4. Certara Inc. (NASDAQ:CERT)

Certara Inc. is a technology-enabled services and software products provider for market access, biosimulation in drug discovery, regulatory submissions, and preclinical and clinical research. It offers its services to biopharmaceutical companies, academic institutions, animal health, the public sector, life sciences companies, and other industries. The stock is up 43% this year and that’s not surprising considering it is a medical AI stock.

Certara brings AI to drug development and research through its platform Certara.ai. Even though the company announces its detailed earnings on the 26th of February, preliminary numbers suggest a revenue growth of over 10%. The company’s software segment continues to drive a major chunk of the growth at 24% YoY while the services segment contributes a healthy 7%.

Bookings growth of 22% shows the company’s product is gaining traction. Analysts have started noticing the stock with Leerink Partners boosting the stock’s price target from $12 to $13 on the back of improved revenue prospects after the Chemaxon acquisition. Both revenue and profits should improve as we progress further in 2025.